N-Acetylcysteine (NAC) Treatment Clinical Trials

3 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 1Phase 4: 1

Top Sponsors

University Hospital, Lille1
Theis S. Itenov1
Fudan University1

Indications

Liver Disease2
Acute Infection1
Severe Infection1
Alcoholic Hepatitis1
Sepsis1

Other3 trials

An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

Phase 2

Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine

Phase 4

PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.